Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-Dopa in models of Parkinson's disease
- 1 September 1991
- journal article
- Published by Springer Nature in Journal Of Neural Transmission-Parkinsons Disease and Dementia Section
- Vol. 3 (3) , 203-213
- https://doi.org/10.1007/bf02259538
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Alleviation of parkinsonism by antagonism of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primateMovement Disorders, 1991
- Effects of classical and novel agents in a MPTP-induced reversible model of Parkinson's diseasePsychopharmacology, 1990
- Reversal of Experimental Parkinsonism by Lesions of the Subthalamic NucleusScience, 1990
- N-Methyl-D-aspartate antagonists stimulate locomotor activity in monoamine depleted rats: Implications for the therapy of Parkinson’s diseasePublished by Springer Nature ,1990
- Effect of the NMDA antagonist MK-801 on MPTP-induced parkinsonism in the monkeyNeuropharmacology, 1989
- Dramatic synergism between MK-801 and clonidine with respect to locomotor stimulatory effect in monoamine-depleted miceJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1989
- 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmosetNeuroscience Letters, 1984
- Glutamate: A Neurotransmitter in Mammalian BrainJournal of Neurochemistry, 1984
- A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.Proceedings of the National Academy of Sciences, 1983
- Chronic parkinsonism secondary to intravenous injection of meperidine analoguesPsychiatry Research, 1979